Last reviewed · How we verify

Fluticasone furoate Nasal Spray 110 mcg

Western Sky Medical Research · FDA-approved active Small molecule Quality 5/100

Fluticasone furoate Nasal Spray 110 mcg is a Small molecule drug developed by Western Sky Medical Research. It is currently FDA-approved. Also known as: Fluticasone Furoate Nasal Spray.

Fluticasone furoate Nasal Spray 110 mcg, marketed by Western Sky Medical Research, is a nasal spray currently available in the market. The key composition patent is set to expire in 2028, providing a period of exclusivity that supports market stability. The primary risk is the potential increase in competition post-patent expiry in 2028.

At a glance

Generic nameFluticasone furoate Nasal Spray 110 mcg
Also known asFluticasone Furoate Nasal Spray
SponsorWestern Sky Medical Research
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fluticasone furoate Nasal Spray 110 mcg

What is Fluticasone furoate Nasal Spray 110 mcg?

Fluticasone furoate Nasal Spray 110 mcg is a Small molecule drug developed by Western Sky Medical Research.

Who makes Fluticasone furoate Nasal Spray 110 mcg?

Fluticasone furoate Nasal Spray 110 mcg is developed and marketed by Western Sky Medical Research (see full Western Sky Medical Research pipeline at /company/western-sky-medical-research).

Is Fluticasone furoate Nasal Spray 110 mcg also known as anything else?

Fluticasone furoate Nasal Spray 110 mcg is also known as Fluticasone Furoate Nasal Spray.

What development phase is Fluticasone furoate Nasal Spray 110 mcg in?

Fluticasone furoate Nasal Spray 110 mcg is FDA-approved (marketed).

Related